Characterization of Ca 2+ current inhibition by cilnidipine using a -subunit antisense oligonucleotide

Author： Uchida R.   Yamazaki J.   Kitamura K.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.466, Iss.1, 2003-04, pp. : 53-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition by antisense oligonucleotides of plasma membrane Ca 2+ ATPase in vascular endothelial cells

By Nakao M.   Furukawa K.-I.   Satoh E.   Ono K.   Iijima T.  

European Journal of Pharmacology, Vol. 387, Iss. 3, 2000-01 ,pp. : 273-277

Elsevier

Access to resources Recommend Favorite

Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex

By Berton M.   Allemann E.   Stein C.A.   Gurny R.  

European Journal of Pharmaceutical Sciences, Vol. 9, Iss. 2, 1999-12 ,pp. : 163-170

Elsevier

Access to resources Recommend Favorite

Antisense oligonucleotide pharmacokinetics and metabolism

By Geary Richard S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 4, 2009-04 ,pp. : 381-391

Informa Healthcare

Access to resources Recommend Favorite

Antisense oligonucleotide therapeutics

By Bennett C.F.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 3, 1999-03 ,pp. : 255-255

Informa Healthcare

Access to resources Recommend Favorite

Antisense Anticancer Oligonucleotide Therapeutics

By  

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-01 ,pp. : 177-196

Bentham Science Publishers

Access to resources Recommend Favorite